These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21327677)

  • 1. Mitomycin C therapy for corneal intraepithelial neoplasia masquerading as limbal stem cell deficiency with recurrent epithelial defect.
    Gokhale NS
    Int Ophthalmol; 2011 Apr; 31(2):161-3. PubMed ID: 21327677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia.
    Dudney BW; Malecha MA
    Am J Ophthalmol; 2004 May; 137(5):950-1. PubMed ID: 15126170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C.
    Haas K; Ben-Dor D; Levartovsky S
    Arch Ophthalmol; 1999 Apr; 117(4):544-5. PubMed ID: 10206591
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C.
    Tseng SH; Tsai YY; Chen FK
    Cornea; 1997 Sep; 16(5):595-7. PubMed ID: 9294697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
    Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S
    Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of conjunctiva-cornea intraepithelial neoplasia successfully treated with topical mitomycin C and interferon alfa-2b in cycles.
    Di Pascuale MA; Espana EM; Tseng SC
    Cornea; 2004 Jan; 23(1):89-92. PubMed ID: 14701965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia.
    Ballalai PL; Erwenne CM; Martins MC; Lowen MS; Barros JN
    Ophthalmic Plast Reconstr Surg; 2009; 25(4):296-9. PubMed ID: 19617789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
    Gebhardt DO
    Am J Ophthalmol; 1998 Mar; 125(3):416-7. PubMed ID: 9512172
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
    Wilson MW; Hungerford JL; George SM; Madreperla SA
    Am J Ophthalmol; 1997 Sep; 124(3):303-11. PubMed ID: 9439356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of mitomycin C for corneal-conjunctival intraepithelial neoplasia: management options--case reports].
    de Figueirêdo RS; de Figueirêdo ES
    Arq Bras Oftalmol; 2006; 69(3):407-11. PubMed ID: 16936968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia.
    Daniell M; Maini R; Tole D
    Clin Exp Ophthalmol; 2002 Apr; 30(2):94-8. PubMed ID: 11886411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
    Shields CL; Naseripour M; Shields JA
    Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution.
    Hirst LW
    Ophthalmology; 2007 May; 114(5):976-82. PubMed ID: 17241666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal invasion of ocular surface squamous neoplasia after clear corneal phacoemulsification: in vivo confocal microscopy analysis.
    Balestrazzi A; Martone G; Pichierri P; Tosi GM; Caporossi A
    J Cataract Refract Surg; 2008 Jun; 34(6):1038-43. PubMed ID: 18499017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitomycin C therapy for corneal intraepithelial neoplasia.
    Frucht-Pery J; Rozenman Y
    Am J Ophthalmol; 1994 Feb; 117(2):164-8. PubMed ID: 8116744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The intraoperative use of mitomycin-C in excision of ocular surface neoplasia with or without limbal autograft transplantation.
    Siganos CS; Kozobolis VP; Christodoulakis EV
    Cornea; 2002 Jan; 21(1):12-6. PubMed ID: 11805500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid response of refractory ocular surface dysplasia to combination treatment with topical all-trans retinoic acid and interferon alfa-2b.
    Skippen B; Tsang HH; Assaad NN; Coroneo MT
    Arch Ophthalmol; 2010 Oct; 128(10):1368-9. PubMed ID: 20938011
    [No Abstract]   [Full Text] [Related]  

  • 19. Tear function and ocular surface changes with topical mitomycin (MMC) treatment for primary corneal intraepithelial neoplasia.
    Dogru M; Erturk H; Shimazaki J; Tsubota K; Gul M
    Cornea; 2003 Oct; 22(7):627-39. PubMed ID: 14508259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.
    Frucht-Pery J; Sugar J; Baum J; Sutphin JE; Pe'er J; Savir H; Holland EJ; Meisler DM; Foster JA; Folberg R; Rozenman Y
    Ophthalmology; 1997 Dec; 104(12):2085-93. PubMed ID: 9400769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.